Antimicrobial effect of cola on several microorganisms

Şeker DAĞ, Hülya ÖZPINAR, Musa SARI, Necati ÖZPINAR
2.304 1.094

Abstract


A study was carried out on three different brands of cola which are marketed in Turkey. Liquid portions of the collected colas were fully removed at 55 oC Antibacterial effect spectrum was determined by Cut Plug method. Minimum Inhibitory Concentrations were determined by micro dilution method by preparing serial dilutions of cola on studied bacterial strains. It was found out that cola has a strong antibacterial effect on Bacillus Cereus, Enterococcus faecalis, Escherichia coli, Escherichia coli O: 157 H: 7, Salmonella enteritidis, Yersinia enterocolitica bacteria and antifungal effect of cola could not be identified. It was considered that cola drinks can be used for the treatment of bacterial factors and bacterial circles causing food toxicity. At the end of the study, a comparison could not be carried out as there was no study on the antibacterial effects of cola on various bacteria. It has been considered that cola beverages can be used for the treatment of bacterial factors and bacterial circles causing food toxicity.

Keywords


Cola, Antibacterial Effect, Bacterial Diarrhea, Cut Plug Method

Full Text:

PDF


References


http://www.kobitek.com_en_cok_taninan_markalarindan_coca- colanin_ dunyasi (2012). http://www.makaleler.com/tarih-makaleleri/tarihte-coca-cola-sirket-tarihinin-bir-ozeti. htm – Makaleler (2012).

Torjesen, I., 2011.Coca-Cola supply chain helps bring diarrhoea treatments to developing World, BMJ 343: d5825 doi: 10.1136/bmj.d5825.

Kapıcıoğlu, S., Baki, A., Reis, A., Tekelioğlu, Y., 1991. Cola drinks consumption and oesophagitis, Dis. Esophagus, 2(4): 306–308.

Pridham, T.G., Lindenfelser, L. A., Shotwell, O.L., Stodola, F., Benedict, R.G., Foley, C., Jacks, P.W., Zaumeyer, W.J., Perston, W.H., Mitchell, J.W, Phytopathology (1956) 46:27.

Anonymous, Clinical laboratory standards institute performance standards for antimicrobial disk and dilution susceptibility tests for bacteria ısolated from animals; approved standard- second edition, (Standards Institute Pennsylvania, USA), 2002. 22(6):1–86.

National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically;Approved Standard – Eighth edition. NCCLS document M7-A6. NCCLS, (Wayne, Pennsylvania, USA), 2003.

Appel, C.C., Myles, T.D., 2001. Caffeine-induced hypokalemic paralysis in pregnancy, Obstet Gynecol, 97(5 Pt 2): 805–807.

Rice, J.E., Faunt, J.D., 2001. Excessive cola consumption as a cause of hypokalemic myopathy, Int Med J. 31:317–318.

Mudge, D.W., Jhonson, D.W., 2004. Coca-Cola and kangaroos, Lancet, 364:1190.

Belpoggı, F., Soffrıttı, M., Tibaldı, E., et al., 2006. Results of Long-Term Carcinogenicity

Bioassays on Coca-Cola Administered to Sprague-Dawley Rats, Ann. N.Y. Acad. Sci. 1076:736–752.

Orbak, R., Dayı, E., Atasever, M., 2002. An experimental study on the effect of acidic drinks on gingival health in dogs, Turk J Vet Anim Sci, 26:1277–1281.

Turgut, M.D., Tekçiçek, M., Çetin, N., Pınar, A., Ölmez, S., Alpar, R., 2004. The erosive effects of some carbonated beverages consumed in Turkey, Journal of Hacettepe Faculty of Dentistry, 28(3): 8–

Rahim, T., Rahim, A., Mohammed, D., Akil, H., 2012. Water sorption characteristics of restorative dental composites immersed in acidic drinks, Dental Materials, 28 (6):e63-e67.

Chung, Y.W., Han, D.S., Par, Y. K., et al., 2006. Huge gastric diospyrobezoars successfully treated by oral intake and endoscopic injection of Coca-Cola, Digestive and Liver Disease, 38: 515– 5

Juan, M., Lapiedra, M., Picazo, V., 2006. Phytobezoar dissolution with Coca-Cola, Gastroenterol Hepatol. 29(5): 291–293.

Saevedra, J.M., 2007.Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action and Practical Aspects. Nutrition in clinical practice, 22: 351–365.

Neish, A., 2009. Microbes in gastrointestinal health and disease. Gastroenterology, 136: 65–80.

Tezcan F I,2007. Intestinal immun sistem. Turkey Clinics J Pediatr Sci. 3(6): 65–66.